BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mall MA, Stahl M, Graeber SY, Sommerburg O, Kauczor H, Wielpütz MO. Early detection and sensitive monitoring of CF lung disease: Prospects of improved and safer imaging: Early Detection and Sensitive Monitoring of CF. Pediatr Pulmonol 2016;51:S49-60. [DOI: 10.1002/ppul.23537] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Davies JC, Drevinek P, Elborn JS, Kerem E, Lee T, Amaral MD, de Boeck K, Davies JC, Drevinek P, Elborn JS, Kerem E, Lee T. Speeding up access to new drugs for CF: Considerations for clinical trial design and delivery. Journal of Cystic Fibrosis 2019;18:677-84. [DOI: 10.1016/j.jcf.2019.06.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
2 Stahl M, Graeber SY, Joachim C, Barth S, Ricklefs I, Diekmann G, Kopp MV, Naehrlich L, Mall MA. Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseases. J Cyst Fibros. 2018;17:249-255. [PMID: 28811149 DOI: 10.1016/j.jcf.2017.08.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
3 Leutz-Schmidt P, Stahl M, Sommerburg O, Eichinger M, Puderbach MU, Schenk JP, Alrajab A, Triphan SMF, Kauczor HU, Mall MA, Wielpütz MO. Non-contrast enhanced magnetic resonance imaging detects mosaic signal intensity in early cystic fibrosis lung disease. Eur J Radiol 2018;101:178-83. [PMID: 29571794 DOI: 10.1016/j.ejrad.2018.02.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
4 Kunz AS, Weng AM, Wech T, Knapp J, Petritsch B, Hebestreit H, Bley TA, Köstler H, Veldhoen S. Non-contrast pulmonary perfusion MRI in patients with cystic fibrosis. Eur J Radiol 2021;139:109653. [PMID: 33838429 DOI: 10.1016/j.ejrad.2021.109653] [Reference Citation Analysis]
5 Goralski JL, Stewart NJ, Woods JC. Novel imaging techniques for cystic fibrosis lung disease. Pediatr Pulmonol 2021;56 Suppl 1:S40-54. [PMID: 32592531 DOI: 10.1002/ppul.24931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lahiri T, Sullivan JS. Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy. Pediatr Pulmonol 2021. [PMID: 34473419 DOI: 10.1002/ppul.25660] [Reference Citation Analysis]
7 Chung C, Bommart S, Marchand-Adam S, Lederlin M, Fournel L, Charpentier MC, Groussin L, Wislez M, Revel MP, Chassagnon G. Long-Term Imaging Follow-Up in DIPNECH: Multicenter Experience. J Clin Med 2021;10:2950. [PMID: 34209147 DOI: 10.3390/jcm10132950] [Reference Citation Analysis]
8 Zhou-Suckow Z, Duerr J, Hagner M, Agrawal R, Mall MA. Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases. Cell Tissue Res 2017;367:537-50. [PMID: 28108847 DOI: 10.1007/s00441-016-2562-z] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 15.2] [Reference Citation Analysis]
9 Wielpütz MO, Mall MA. MRI accelerating progress in functional assessment of cystic fibrosis lung disease. Journal of Cystic Fibrosis 2017;16:165-7. [DOI: 10.1016/j.jcf.2016.12.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
10 Willers C, Bauman G, Andermatt S, Santini F, Sandkühler R, Ramsey KA, Cattin PC, Bieri O, Pusterla O, Latzin P. The impact of segmentation on whole-lung functional MRI quantification: Repeatability and reproducibility from multiple human observers and an artificial neural network. Magn Reson Med 2021;85:1079-92. [PMID: 32892445 DOI: 10.1002/mrm.28476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Mueller J, Karrasch S, Lorbeer R, Ivanovska T, Pomschar A, Kunz WG, von Krüchten R, Peters A, Bamberg F, Schulz H, Schlett CL. Automated MR-based lung volume segmentation in population-based whole-body MR imaging: correlation with clinical characteristics, pulmonary function testing and obstructive lung disease. Eur Radiol 2019;29:1595-606. [PMID: 30151641 DOI: 10.1007/s00330-018-5659-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Wielpütz MO, von Stackelberg O, Stahl M, Jobst BJ, Eichinger M, Puderbach MU, Nährlich L, Barth S, Schneider C, Kopp MV, Ricklefs I, Buchholz M, Tümmler B, Dopfer C, Vogel-claussen J, Kauczor H, Mall MA. Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosis. Journal of Cystic Fibrosis 2018;17:518-27. [DOI: 10.1016/j.jcf.2018.05.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 10.3] [Reference Citation Analysis]
13 Turkovic L, Caudri D, Rosenow T, Breuer O, Murray C, Tiddens HA, Ramanauskas F, Ranganathan SC, Hall GL, Stick SM. Structural determinants of long-term functional outcomes in young children with cystic fibrosis. Eur Respir J 2020;55:1900748. [DOI: 10.1183/13993003.00748-2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
14 Stahl M, Joachim C, Kirsch I, Uselmann T, Yu Y, Alfeis N, Berger C, Minso R, Rudolf I, Stolpe C, Bovermann X, Liboschik L, Steinmetz A, Tennhardt D, Dörfler F, Röhmel J, Unorji-Frank K, Rückes-Nilges C, von Stoutz B, Naehrlich L, Kopp MV, Dittrich AM, Sommerburg O, Mall MA. Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases. ERJ Open Res 2020;6:00408-2020. [PMID: 33263048 DOI: 10.1183/23120541.00408-2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Dournes G, Walkup LL, Benlala I, Willmering MM, Macey J, Bui S, Laurent F, Woods JC. The Clinical Use of Lung MRI in Cystic Fibrosis: What, Now, How? Chest 2021;159:2205-17. [PMID: 33345950 DOI: 10.1016/j.chest.2020.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Balázs A, Mall MA. Mucus obstruction and inflammation in early cystic fibrosis lung disease: Emerging role of the IL-1 signaling pathway. Pediatr Pulmonol 2019;54 Suppl 3:S5-S12. [PMID: 31715090 DOI: 10.1002/ppul.24462] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
17 Bischoff A, Weinheimer O, Eichinger M, Stahl M, Sommerburg O, Kauczor HU, Mall MA, Wielpütz MO. [Cystic fibrosis and computed tomography of the lungs]. Radiologe 2020;60:791-801. [PMID: 32621155 DOI: 10.1007/s00117-020-00713-2] [Reference Citation Analysis]
18 Woods JC, Wild JM, Wielpütz MO, Clancy JP, Hatabu H, Kauczor HU, van Beek EJR, Altes TA. Current state of the art MRI for the longitudinal assessment of cystic fibrosis. J Magn Reson Imaging 2020;52:1306-20. [PMID: 31846139 DOI: 10.1002/jmri.27030] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
19 Leutz-Schmidt P, Eichinger M, Stahl M, Sommerburg O, Biederer J, Kauczor HU, Puderbach MU, Mall MA, Wielpütz MO. Ten years of chest MRI for patients with cystic fibrosis : Translation from the bench to clinical routine. Radiologe 2019;59:10-20. [PMID: 31172247 DOI: 10.1007/s00117-019-0553-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
20 Bayfield KJ, Douglas TA, Rosenow T, Davies JC, Elborn SJ, Mall M, Paproki A, Ratjen F, Sly PD, Smyth AR, Stick S, Wainwright CE, Robinson PD. Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis. Thorax 2021:thoraxjnl-2020-216085. [PMID: 33927017 DOI: 10.1136/thoraxjnl-2020-216085] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Stahl M, Wielpütz MO, Kauczor HU, Mall MA; all authors. Reply to Verbanck and Vanderhelst: The Respective Roles of Lung Clearance Index and Magnetic Resonance Imaging in the Clinical Management of Patients with Cystic Fibrosis. Am J Respir Crit Care Med 2018;197:410-1. [PMID: 28800247 DOI: 10.1164/rccm.201707-1367LE] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Van Stormbroek B, Zampoli M, Morrow BM. Nebulized gentamicin in combination with systemic antibiotics for eradicating early Pseudomonas aeruginosa infection in children with cystic fibrosis. Pediatr Pulmonol 2019;54:393-8. [DOI: 10.1002/ppul.24254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Stahl M, Wielpütz MO, Ricklefs I, Dopfer C, Barth S, Schlegtendal A, Graeber SY, Sommerburg O, Diekmann G, Hüsing J, Koerner-rettberg C, Nährlich L, Dittrich A, Kopp MV, Mall MA. Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study. Am J Respir Crit Care Med 2019;199:1238-48. [DOI: 10.1164/rccm.201807-1203oc] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
24 Stahl M, Steinke E, Mall MA. Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis. Genes (Basel) 2021;12:803. [PMID: 34070354 DOI: 10.3390/genes12060803] [Reference Citation Analysis]
25 Montgomery ST, Dittrich AS, Garratt LW, Turkovic L, Frey DL, Stick SM, Mall MA, Kicic A; AREST CF. Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis. J Cyst Fibros 2018;17:715-22. [PMID: 29884450 DOI: 10.1016/j.jcf.2018.05.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
26 Santyr G, Kanhere N, Morgado F, Rayment JH, Ratjen F, Couch MJ. Hyperpolarized Gas Magnetic Resonance Imaging of Pediatric Cystic Fibrosis Lung Disease. Academic Radiology 2019;26:344-54. [DOI: 10.1016/j.acra.2018.04.024] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
27 Mondéjar-López P, Horsley A, Ratjen F, Bertolo S, de Vicente H, Asensio de la Cruz Ò. A multimodal approach to detect and monitor early lung disease in cystic fibrosis. Expert Rev Respir Med 2021;15:761-72. [PMID: 33843417 DOI: 10.1080/17476348.2021.1908131] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel P, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-hamblett N, Kashirskaya N, Kerem E, Mathew JL, Mckone EF, Naehrlich L, Nasr SZ, Oates GR, O'neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F. The future of cystic fibrosis care: a global perspective. The Lancet Respiratory Medicine 2020;8:65-124. [DOI: 10.1016/s2213-2600(19)30337-6] [Cited by in Crossref: 183] [Cited by in F6Publishing: 82] [Article Influence: 91.5] [Reference Citation Analysis]
29 Khan MA, Ali ZS, Sweezey N, Grasemann H, Palaniyar N. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation. Genes (Basel) 2019;10:E183. [PMID: 30813645 DOI: 10.3390/genes10030183] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]